Marker Therapeutics, Inc. (MRKR)
1.15
-0.05
(-4.17%)
USD |
NASDAQ |
Sep 11, 16:00
1.16
+0.01
(+0.87%)
After-Hours: 20:00
Marker Therapeutics Price to Book Value : 1.576 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.576 |
| September 10, 2026 | 1.645 |
| September 09, 2026 | 1.658 |
| September 08, 2026 | 1.754 |
| September 04, 2026 | 1.617 |
| September 03, 2026 | 1.699 |
| September 02, 2026 | 1.713 |
| September 01, 2026 | 1.782 |
| August 31, 2026 | 1.823 |
| August 28, 2026 | 1.878 |
| August 27, 2026 | 2.001 |
| August 26, 2026 | 1.987 |
| August 25, 2026 | 2.083 |
| August 24, 2026 | 2.056 |
| August 21, 2026 | 1.905 |
| August 20, 2026 | 1.672 |
| August 19, 2026 | 1.768 |
| August 18, 2026 | 1.576 |
| August 17, 2026 | 1.590 |
| August 14, 2026 | 1.562 |
| August 13, 2026 | 1.521 |
| August 12, 2026 | 1.590 |
| August 11, 2026 | 1.535 |
| August 10, 2026 | 1.576 |
| August 07, 2026 | 1.535 |
| Date | Value |
|---|---|
| August 06, 2026 | 1.535 |
| August 05, 2026 | 1.562 |
| August 04, 2026 | 1.686 |
| August 03, 2026 | 1.672 |
| July 31, 2026 | 1.549 |
| July 30, 2026 | 1.535 |
| July 29, 2026 | 1.521 |
| July 28, 2026 | 1.617 |
| July 27, 2026 | 1.672 |
| July 24, 2026 | 1.672 |
| July 23, 2026 | 1.741 |
| July 22, 2026 | 1.699 |
| July 21, 2026 | 1.741 |
| July 20, 2026 | 1.754 |
| July 17, 2026 | 1.795 |
| July 16, 2026 | 1.836 |
| July 15, 2026 | 1.932 |
| July 14, 2026 | 1.974 |
| July 13, 2026 | 2.001 |
| July 10, 2026 | 2.070 |
| July 09, 2026 | 2.165 |
| July 08, 2026 | 2.206 |
| July 07, 2026 | 2.302 |
| July 06, 2026 | 2.028 |
| July 02, 2026 | 2.015 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ironwood Pharmaceuticals, Inc. | -- |
| SELLAS Life Sciences Group, Inc. | 16.93 |
| Rezolute, Inc. | 3.478 |
| Krystal Biotech, Inc. | 7.556 |
| Larimar Therapeutics, Inc. | 3.212 |
Price to Book Value Related Metrics
| PS Ratio | 8.867 |
| Price | 1.15 |
| Earnings Yield | -41.80% |
| Market Cap | 19.17M |